Clinical Trials Browser

Withdrawn × Recurrence × daratumumab × Clear all

NCT06232707 2024-05-31

ALUMMINATE

Phase 3 Withdrawn

Multiple Myeloma, Recurrence

NCT05408026 2023-01-27

Study of Combination POM, BTZ, Low-Dose DEX, and DARA (PVD-DARA) in Patients With RRMM

Phase 1/2 Withdrawn

Multiple Myeloma, Recurrence